HD Visual Learning

The Impact of Clinical Trials in the Management of Polypoidal Choroidal Neovascularization (PCV)

Examination of essential diagnostic tools, distinguishing features of PCV, and how clinical trials for anti-vascular endothelial growth factor (anti-VEGF) agents with both monotherapy and combination photodynamic therapy have impacted management of this macula-scarring disease.

The Impact of Clinical Trials in the Management of Myopic Choroidal Neovascularization (mCNV)

Investigation of critical features of mCNV and how clinical trials for anti-vascular endothelial growth factor (anti-VEGF) agents have impacted the management of this vision-threatening complication of pathologic myopia.

The Impact of Clinical Trials in the Management of Retinal Vein Occlusion

Exploration of how clinical trials and advancements in treatment with intravitreal vascular endothelial growth factor (VEGF) inhibitors have impacted the management of Retinal Vein Occlusion.

The Impact of Clinical Trials in the Management of Age-Related Macular Degeneration

Exploration of how clinical trials and advancements in treatment with intravitreal vascular endothelial growth factor (VEGF) inhibitors have impacted the management of Age-Related Macular Degeneration.

The Impact of Clinical Trials in the Management of DR and DME

Exploration of how clinical trials and advancements in treatment with intravitreal vascular endothelial growth factor (VEGF) inhibitors have impacted the management of diabetic retinopathy (DR) and diabetic macular edema (DME).